📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial. (2019)

First Author: Tsai JN
Attributed to:  Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2213-8587(19)30255-4

PubMed Identifier: 31447409

Publication URI: http://europepmc.org/abstract/MED/31447409

Type: Journal Article/Review

Volume: 7

Parent Publication: The lancet. Diabetes & endocrinology

Issue: 10

ISSN: 2213-8587